1.68
price up icon2.44%   0.04
pre-market  Vorhandelsmarkt:  1.82   0.14   +8.33%
loading
Schlusskurs vom Vortag:
$1.64
Offen:
$1.69
24-Stunden-Volumen:
251.32K
Relative Volume:
1.19
Marktkapitalisierung:
$27.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.29M
KGV:
-2.40
EPS:
-0.7
Netto-Cashflow:
$-6.47M
1W Leistung:
+20.43%
1M Leistung:
+25.37%
6M Leistung:
+41.18%
1J Leistung:
-14.29%
1-Tages-Spanne:
Value
$1.6407
$1.70
1-Wochen-Bereich:
Value
$1.41
$1.70
52-Wochen-Spanne:
Value
$0.94
$2.55

NanoViricides Inc Stock (NNVC) Company Profile

Name
Firmenname
NanoViricides Inc
Name
Telefon
203-937-6137
Name
Adresse
1 Controls Drive, Shelton, CT
Name
Mitarbeiter
7
Name
Twitter
@nnvcnyse
Name
Nächster Verdiensttermin
2025-05-20
Name
Neueste SEC-Einreichungen
Name
NNVC's Discussions on Twitter

Vergleichen Sie NNVC mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
NNVC
NanoViricides Inc
1.68 22.42M 0 -8.29M -6.47M -0.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
459.81 120.40B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
542.52 61.30B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.53 41.06B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
564.59 34.29B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.55 27.09B 3.81B -644.79M -669.77M -6.24

NanoViricides Inc Stock (NNVC) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2015-02-11 Eingeleitet Midtown Partners Strong Buy

NanoViricides Inc Aktie (NNVC) Neueste Nachrichten

pulisher
Jul 20, 2025

NanoViricides Inc. Stock Analysis and ForecastHigh-yield investments - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 20, 2025

What analysts say about NanoViricides Inc. stockExceptional stock performance - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 19, 2025

What drives NanoViricides Inc. stock priceBreakneck growth rates - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

Is NanoViricides Inc. a good long term investmentFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 17, 2025

Mpox Antiviral Clinical Trial Advances as WHO Extends Global Emergency - Global Biodefense

Jul 17, 2025
pulisher
Jul 16, 2025

WHO Extended Global Emergency Status of MPox EpidemicDevelopment of Treatment for MPox with NV-387 is Timely, Says NanoViricides - Great Falls Tribune

Jul 16, 2025
pulisher
Jul 16, 2025

NanoViricides Advances MPox Treatment Development Amid WHO's Extended Health Emergency - citybuzz -

Jul 16, 2025
pulisher
Jul 16, 2025

NanoViricides says MPox drug candidate NV-387 poised for Phase II trial as WHO extends global health emergency - Proactive financial news

Jul 16, 2025
pulisher
Jul 16, 2025

D.C. United Roofing Inc. Wins 2025 Consumer Choice Award for Roofing in Barrie - The Palm Beach Post

Jul 16, 2025
pulisher
Jul 16, 2025

NanoViricides Targets Multi-Billion MPox Market with Superior Treatment as WHO Extends Global Emergency - Stock Titan

Jul 16, 2025
pulisher
Jul 15, 2025

Go Industries Inc. Unveils Durable Winch Grille Guard for Unmatched Vehicle Protection - The Palm Beach Post

Jul 15, 2025
pulisher
Jul 15, 2025

How NanoViricides Inc. stock performs during market volatilityFree Best Stocks to Buy Today - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes NanoViricides Inc. stock price move sharplyReal Time Breakout Tracking - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why NanoViricides Inc. stock attracts strong analyst attention3x Return Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

NanoViricides positioned at forefront of Mpox treatment efforts, says Zacks - Proactive financial news

Jul 15, 2025
pulisher
Jul 15, 2025

Small cap wrap: Lisata Therapeutics, Uranium American Resources, Nano One Materials... - Proactive financial news

Jul 15, 2025
pulisher
Jul 14, 2025

Market movers: Autodesk, Waters, NanoViricides... - Proactive financial news

Jul 14, 2025
pulisher
Jul 14, 2025

NNVC: NanoViricides Set to Initiate Phase 2 Trial in MPox - Zacks Small Cap Research

Jul 14, 2025
pulisher
Jul 14, 2025

Adaptive Clinical Protocol Design for Phase II MPox Clade I Treatment with a Novel Broad-Spectrum Drug NV-387 is Almost Complete, Reports NanoViricides - Worcester Telegram

Jul 14, 2025
pulisher
Jul 14, 2025

NanoViricides nears completion of clinical trial design for MPox treatment - Proactive financial news

Jul 14, 2025
pulisher
Jul 14, 2025

Dallas Central's Welborn Garage Receives 2025 Consumer Choice Award for Garage & Overhead Doors - The Palm Beach Post

Jul 14, 2025
pulisher
Jul 14, 2025

Breakthrough MPox Drug NV-387 Targets Deadly Clade I Strain as Phase II Trial Takes Shape - Stock Titan

Jul 14, 2025
pulisher
Jul 13, 2025

Folsom Homeowners Rejoice: All Pro Overhead Garage Doors Elevates Garage Door Opener Repair Services - Sarasota Herald-Tribune

Jul 13, 2025
pulisher
Jul 12, 2025

Wealth Enhancement Advisory Services LLC Invests $26,000 in NanoViricides, Inc. (NYSE:NNVC) - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Helios Secures $4M Seed Round to Build First AI-Native Operating System for Public Policy Professionals - The Palm Beach Post

Jul 11, 2025
pulisher
Jul 11, 2025

Moderna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 - Milwaukee Journal Sentinel

Jul 11, 2025
pulisher
Jul 08, 2025

New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration - Asbury Park Press

Jul 08, 2025
pulisher
Jul 08, 2025

PrivateJet.com Launches a New Era in On-Demand Luxury Air Travel - The Arizona Republic

Jul 08, 2025
pulisher
Jul 07, 2025

MicroGenDX Transforms Infectious Disease Diagnostics With Innovative 24-Hour Testing Technology - The Daily Jeffersonian

Jul 07, 2025
pulisher
Jul 07, 2025

Will Scott Presented “5 Key Insights for Mastering Generative Engine Optimization” at SMX Advanced Boston - Daily Commercial

Jul 07, 2025
pulisher
Jul 07, 2025

NanoViricides (NNVC) Accelerates MPox Drug Development, Citing Strong Business and Public Health Case - The Globe and Mail

Jul 07, 2025
pulisher
Jul 05, 2025

NanoViricides (NYSE:NNVC) Trading Up 0.7% – Still a Buy? - Defense World

Jul 05, 2025
pulisher
Jul 02, 2025

NanoViricides advances antiviral candidate NV-387 into Phase 2 trials for Mpox - Proactive Investors

Jul 02, 2025
pulisher
Jul 01, 2025

Keathley Landscaping Leads Sod Installation Companies in Wylie with Expert Services - The Palm Beach Post

Jul 01, 2025
pulisher
Jul 01, 2025

There is a Strong Business Case for Phase II Clinical Program for Treatment of MPox Infection Using NV-387, an Industry-Leading Broad-Spectrum Antiviral Drug Candidate - Worcester Telegram

Jul 01, 2025
pulisher
Jun 26, 2025

NanoViricides (NYSE:NNVC) and Gemini Therapeutics (NASDAQ:GMTX) Head-To-Head Review - Defense World

Jun 26, 2025
pulisher
Jun 18, 2025

With Rising Variants of COVID and Bird Flu, the Single Broad-Spectrum Antiviral NV-387 Would be the Best Partner for Preparedness, Says NanoViricides' Dr. Diwan - Knoxville News Sentinel

Jun 18, 2025
pulisher
Jun 18, 2025

NanoViricides' NV-387 Emerges as a Promising Broad-Spectrum Antiviral Against COVID-19 and Bird Flu - citybuzz -

Jun 18, 2025
pulisher
Jun 18, 2025

Small cap wrap: Fineqia, NanoViricides, Standard Uranium... - Proactive financial news

Jun 18, 2025
pulisher
Jun 18, 2025

NanoViricides touts antiviral NV-387 as tool against new COVID variant - Proactive financial news

Jun 18, 2025

Finanzdaten der NanoViricides Inc-Aktie (NNVC)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.88
price down icon 0.59%
$35.59
price up icon 0.34%
$102.56
price down icon 1.55%
$26.20
price down icon 5.18%
$110.02
price down icon 0.92%
biotechnology ONC
$294.55
price up icon 1.45%
Kapitalisierung:     |  Volumen (24h):